Publications

The physicians at MHB are world leaders in men’s health research.

Below are several publications by MHB physicians that are widely cited in the medical literature

To open the article pdf in new browser window, click the title.
To download and save article, right-click and chose “Save As..”.

Clinical research by Dr. Morgentaler and his physicians – links to abstracts on PubMed:

Click the titles below to slide open/close the accordions.

Will I have a heart attack or stroke if I take testosterone therapy?
Morgentaler A.
J Sex Med. 2014 Jun;11(6):1601-2. No abstract available.

Does Testosterone Increase the Risk of a Cardiovascular Event?
Seftel AD, Morgentaler A.
J Urol. 2014 Apr 16. No abstract available.

Deaths and cardiovascular events in men receiving testosterone.
Morgentaler A, Traish A, Kacker R.
JAMA. 2014 Mar 5;311(9):961-2. No abstract available.

Andrology: Testosterone and cardiovascular risk – deciphering the statistics.
Morgentaler A, Kacker R.
Nat Rev Urol. 2014 Mar;11(3):131-2. Epub 2014 Feb 18. No abstract available.

Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden EL, Morgentaler A.
N Engl J Med. 2004 Jan 29;350(5):482-92. Review. No abstract available.

Factors Influencing Prostate-Specific Antigen Response among Men Treated with Testosterone Therapy for 6 Months.
Morgentaler A, Benesh JA, Denes BS, Kan-Dobrosky N, Harb D, Miller MG.
J Sex Med. 2014 Nov;11(11):2818-25. Epub 2014 Aug 18.

A new era of testosterone and prostate cancer: from physiology to clinical implications.
Khera M, Crawford D, Morales A, Salonia A, Morgentaler A.
Eur Urol. 2014 Jan;65(1):115-23. Epub 2013 Aug 16. Review.
Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.
Balbontin FG, Moreno SA, Bley E, Chacon R, Silva A, Morgentaler A.
BJU Int. 2014 Jul;114(1):125-30.

Testosterone and prostate cancer: what are the risks for middle-aged men?
Morgentaler A.
Urol Clin North Am. 2011 May;38(2):119-24. Epub 2011 Apr 13. Review.

Is testosterone a friend or a foe of the prostate?
Jannini EA, Gravina GL, Morgentaler A, Morales A, Incrocci L, Hellstrom WJ.
J Sex Med. 2011 Apr;8(4):946-55.

An outcomes analysis of over 200 revision surgeries for penile prosthesis implantation: a multicenter study.
Henry GD, Donatucci CF, Conners W, Greenfield JM, Carson CC, Wilson SK, Delk J, Lentz AC, Cleves MA, Jennermann CJ, Kramer AC.
J Sex Med. 2012 Jan;9(1):309-15. Epub 2011 Nov 14.

Occult prostate cancer in men with low serum testosterone levels.
Morgentaler A, Bruning CO 3rd, DeWolf WC.
JAMA. 1996 Dec 18;276(23):1904-6.

Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men.
Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, Jones TH.
Andrology. 2014 Nov;2(6):819-34. Epub 2014 Oct 1.

Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
Kacker R, Harisaran V, Given L, Miner M, Rittmaster R, Morgentaler A.
Andrologia. 2014 Feb 6. doi: 10.1111/and.12237.

Management of impending sterility.
Maranchie J, Morgentaler A.
Lancet. 1996 May 11;347(9011):1344. No abstract available.

Reclaim Your Freedom